[ Price : $8.95]
FDA encourages drug sponsors to use centralized statistical monitoring to help keep an eye on clinical trial integrity issues.[ Price : $8.95]
Lawyers on a Food & Drug Law Institute enforcement panel warn that the incoming Trump administration is likely to target and seek ...[ Price : $8.95]
FDA says it has identified serious liver injuries in patients without cirrhosis of the liver being treated for primary biliary cho...[ Price : $8.95]
A detailed ProPublica investigative report says FDA failed to inspect a Glenmark Pharmaceuticals facility in India that had multip...[ Price : $8.95]
After receiving a complete response letter, Lykos Therapeutics says it will pursue FDAs dispute resolution process to question the...[ Price : $8.95]
Reed Smith attorney James Beck says companies hit by FDA for off-label promotion may challenge the agencys reasoning under the new...[ Price : $8.95]
FDA extends by three months its review of a Syndax Pharmaceuticals NDA for revumenib and its use in treating adult and pediatric p...[ Price : $8.95]
A detailed FDLI analysis looks at how expected Supreme Court changes to the Chevron federal agency deference principle will likely...